Texas Prescription Monitoring Program (PMP) Privacy Laws: Sharing Opioid Dispensing Reports with Clinics

Texas Prescription Monitoring Program (PMP) privacy rules aim to reduce misuse of controlled substances while protecting patient confidentiality. This guide explains how opioid dispensing reports can be shared with clinics, who may access PMP data, required documentation, and the precise exceptions that apply under Texas law and board rules. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

PMP Reporting Requirements

What must be reported and when

All Texas‑licensed pharmacies must report dispensations of Schedule II–V controlled substances to the Texas PMP no later than the next business day after a prescription is completely filled. This reporting duty also applies to pharmacies located outside Texas that dispense to Texas residents. ([pharmacy.texas.gov](https://www.pharmacy.texas.gov/PMP/?utm_source=openai))

Zero‑reporting and compliance monitoring

If a pharmacy dispenses no controlled substances for seven consecutive days, it must submit a “zero report,” unless it has an approved waiver. The State Auditor notes the Board monitors compliance and flags delinquent dispensers. ([law.cornell.edu](https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-315-6?utm_source=openai))

Statute reinforces the reporting timeline and zero‑reporting requirement, framing these duties within Texas’ controlled substance reporting framework. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

PMP Access for Clinics

Who in a clinic may access PMP data

Clinics typically access opioid dispensing histories through individual practitioner or pharmacist accounts in PMP AWARxE; eligible users must hold an active Texas license. In addition, a “health care facility certified by the federal Centers for Medicare & Medicaid Services (CMS)” is recognized in statute as an authorized recipient of PMP data. ([pmpawarxe.zendesk.com](https://pmpawarxe.zendesk.com/hc/en-us/articles/29229933287827-Texas?utm_source=openai))

EHR integration versus portal access

Texas allows EHR/HIE integration with PMP for compliant workflow. However, delegates are not permitted to access PMP data via EHR or pharmacy system integrations and must use the web portal instead. ([pharmacy.texas.gov](https://www.pharmacy.texas.gov/files_pdf/TexasIntegrationWelcomePacket.pdf?utm_source=openai))

Sharing opioid dispensing reports with clinics

When sharing PMP information, transmit it to an authorized practitioner (or that practitioner’s approved delegate) involved in the patient’s care, or incorporate it into the patient’s medical record. Texas law expressly permits authorized users to include PMP information in any form in the patient’s medical or pharmacy record; once included, it is protected by applicable privacy laws. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

Authorized Access Delegation

Who may delegate and to whom

Under board rules, a pharmacist may delegate PMP access to a pharmacist‑intern, pharmacy technician, or technician trainee acting under the pharmacist’s direction. A practitioner may delegate access to an employee or other agent acting at the practitioner’s direction for treatment‑related queries. ([law.cornell.edu](https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-315-11?utm_source=openai))

Delegate setup and oversight

Supervisors approve and manage delegates in PMP AWARxE and must periodically re‑verify delegate status. Programs recognize both licensed and unlicensed delegate roles for practitioners, with oversight and auditing available within AWARxE. ([pharmacy.texas.gov](https://www.pharmacy.texas.gov/files_pdf/pmp/TX-PMP-AWARxE-User-Support-Manual.pdf?utm_source=openai))

Important limitation

Delegates cannot use EHR or pharmacy system “gateway” integrations to access Texas PMP; they must log in through the web portal to run reports. ([pharmacy.texas.gov](https://www.pharmacy.texas.gov/files_pdf/TexasIntegrationWelcomePacket.pdf?utm_source=openai))

Compliance Mandate for Prescribers

Mandatory PMP checks

Effective March 1, 2020, prescribers (other than veterinarians) must check the PMP before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol. Pharmacists must also consult the PMP before dispensing these drugs. ([tmb.texas.gov](https://www.tmb.texas.gov/apply-renew/physician/prescribing-and-supervision?utm_source=openai))

Documenting the review (medical record documentation)

Best practice—and TMB guidance—is to document the review in the patient’s medical record, including the date of the review and identity of the reviewer. If your EHR integrates PMP data, an in‑workflow review satisfies the rule; in some systems, you must open the full report (not just a risk score) to comply. ([tmb.texas.gov](https://www.tmb.texas.gov/254-what-amount-detail-must-be-documentation-pmp-check?utm_source=openai))

Exceptions to PMP Consultation

When the check is not required

• Documented diagnosis of cancer, sickle cell disease, or the patient is receiving hospice care. The prescriber must clearly note this in the prescription or medical record. ([tcss.legis.texas.gov](https://tcss.legis.texas.gov/resources/hs/htm/hs.481.htm?utm_source=openai))
• Inpatient hospital medication orders and outpatient encounters in settings such as emergency departments or ambulatory surgery centers (orders for on‑site administration). ([txrules.elaws.us](https://txrules.elaws.us/rule/title22_chapter170_sec.170.9?utm_source=openai))
• Good‑faith attempt to check the PMP but unable to access due to circumstances outside the prescriber’s or dispenser’s control (e.g., system outage), with the attempt documented. ([tcss.legis.texas.gov](https://tcss.legis.texas.gov/resources/hs/htm/hs.481.htm?utm_source=openai))

APRNs follow the same statutory exceptions, including inpatient orders and the cancer/sickle cell/hospice carve‑outs. ([nursing.texas.gov](https://www.nursing.texas.gov/faq_practice_aprn.asp.html?utm_source=openai))

Legal Framework for Data Sharing

Confidentiality and permitted recipients

PMP data is confidential and not subject to public disclosure; unauthorized use or disclosure can trigger administrative penalties. Authorized recipients include practitioners and pharmacists (and their delegates), CMS‑certified health care facilities, certain licensing agencies, law enforcement with a court order, and out‑of‑state PDMPs under interoperability agreements. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

Inter‑state data sharing

Texas may share and receive PMP data through interstate interoperability (e.g., NABP PMP InterConnect) to support clinical decision‑making and opioid dispensing compliance across state lines. ([tcss.legis.texas.gov](https://tcss.legis.texas.gov/resources/hs/htm/hs.481.htm?utm_source=openai))

Including PMP data in the record and penalties

Authorized users may include PMP information “in any form” in the patient’s medical or pharmacy record; once included, it is governed by state and federal privacy protections. Violations for improper access or disclosure can result in administrative penalties under board rules. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

Patient Access Program

How patients obtain their PMP history

Patients (or a parent/legal guardian, as applicable) can request a copy of their Texas PMP record—including a list of who accessed it—by submitting a notarized Patient Access Request Form with required identification to the Texas State Board of Pharmacy. ([pharmacy.texas.gov](https://www.pharmacy.texas.gov/patient-access/?utm_source=openai))

Rule requirements

Board rule 22 TAC §315.16 details the process and required documentation for patient requests. The PMP statute also confirms the right to receive the record and access log upon proper request. ([law.cornell.edu](https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-315-16?utm_source=openai))

Conclusion

To share opioid dispensing reports with clinics lawfully, ensure an authorized user initiates the query, transmit information only to a practitioner or approved delegate engaged in the patient’s care, and document your review and any applicable exceptions. Follow Texas’ prescription monitoring program regulations for controlled substance reporting, respect patient confidentiality protections, and leverage inter‑state data sharing and EHR integrations where permitted to streamline opioid dispensing compliance. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

FAQs

What are the privacy requirements for sharing PMP data with clinics?

PMP information is confidential and may be shared only with authorized recipients for patient care and related operations. In practice, send the report to the treating practitioner or that practitioner’s approved delegate, or place it in the patient’s medical record—where it is protected by state and federal privacy laws. Unauthorized disclosure can result in administrative penalties. ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/DocViewer.aspx?DocKey=HS%2FHS.481&ExactPhrase=False&HighlightType=1&Phrases=tramadol&QueryText=tramadol&utm_source=openai))

How do clinics access opioid dispensing reports under Texas PMP laws?

Clinics access PMP data through licensed prescribers’ or pharmacists’ AWARxE accounts (and their delegates). Some CMS‑certified facilities may also access data, and EHR integrations are allowed for eligible users; delegates must use the web portal rather than EHR integrations. ([pmpawarxe.zendesk.com](https://pmpawarxe.zendesk.com/hc/en-us/articles/29229933287827-Texas?utm_source=openai))

Who is authorized to delegate access to the Texas PMP?

Practitioners may delegate PMP access to employees or agents acting under their direction; pharmacists may delegate to interns, technicians, or technician trainees working under their supervision. Supervisors approve and manage delegates within AWARxE and must periodically re‑verify them. ([law.cornell.edu](https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-315-11?utm_source=openai))

What exceptions exist for PMP consultation when prescribing opioids?

Mandatory checks are waived for patients with documented cancer or sickle cell disease, patients receiving hospice care, inpatient hospital medication orders, outpatient ED/ASC encounters, and documented good‑faith inability to access the PMP due to factors outside the prescriber’s control. ([tcss.legis.texas.gov](https://tcss.legis.texas.gov/resources/hs/htm/hs.481.htm?utm_source=openai))